Chinese vaccine supplies the research and development ability of the system and lags behind Supportability is insufficient
Sino-Singaporean network, December 30 is according to the news of Chinese Government net, General Office of the State Council announces today vaccine supplies the construction plan of the system. Plan to point out, Chinese vaccine supplies every link of the system and exposes some outstanding problems, including research and development ability relatively lags behind, such questions as the supportability of meeting an urgent need is insufficient. Plan to claim, refered vaccine of this planning supplies the system, refer to preventing and controlling infectious disease, tackling, happening suddenly the intact system that the public health event involved through vaccine inoculation, including the epidemic situation monitors links such as prewarning and vaccine researching and developing, production, circulation, inoculating, storing, supervising,etc.. Perfecting vaccine supplies the system and keeps high-efficient operation, research and development is produced with vaccine inoculation in time, it is the key to preventing and controlling epidemic situation effectively, it is significant to ensuring the people's life and health, safeguarding the economic social stability. Plan to point out, China has now vaccine that can basically meet the regular epidemic prevention demand, but higher and higher with masses' requirements for life and health, health epidemic prevention of people, in addition severe acute respiratory syndrome, first type H1N1 influenza,etc. are serious with sending infectious disease to present constantly newly, vaccine supplies every link of the system and exposes some outstanding problems: 1. Infectious disease monitors the early warning level low. The intersection of infectious disease and case diagnose according to clinical symptom by doctor more, bacterium, virus, fungi pathogen diagnose reagent products lean towards little and application level relatively low. 2.Research and development ability is relatively backward. The basic research of vaccine of our country is weak, it is not complete to appraise and support the system vaccine quality and result. Lack innovative and high side and research and develop talents. 3.The production capacity of scale is weak. The advanced large-scale production technology is deficient. 4.Vaccine management remains to strengthen. The supplies management of vaccine involves a plurality of departments, lack the overall coordination at present. Vaccine is comparatively weak in management of circulating. The unusual reaction compensation mechanism of vaccine inoculation has not been set up yet. 5.The supportability of meeting an urgent need is insufficient. Vaccine technological reserve and production capacity store insufficiently, it is difficult to research and develop and expand producing urgently in a large amount fast. There are partial and few official reserves variety, quantity, should break out and produce the means to fluctuate to the epidemic situation in surprise weakly on a large scale. Have not formed and dealt with the overall emergency response mechanism from monitoring, inoculating the bad reaction promptly in epidemic situation to yet. 6.Forming mechanism remains to be complete at the price. Limited by many kinds of factors, plan the overall level of government issused price of vaccine on the low side in national immunity, the space of profit is relatively young, influence enterprises to improve product quality and carry on the enthusiasm of updating and upgrading of a product to a certain extent. The second type vaccine is the products of price of market regulation, more links of circulatings, the market price is a bit high. 7.The inoculating rate still needs to improve to plan vaccine actually in immunity. Some place implement immunity plan, in the course, store township, at village level immunization campaign in funds implement and cold chain build, form a complete set with basic unit inoculating problemming such as being undermanned, lead to the fact immune planning is uneven in progress, influence the improvement of the inoculating rate actually of vaccine. 8.People's beast's altogether ill beast uses the integral level of vaccine non- high. People's beast's altogether ill early warning ability of monitoring is weak. Research and develop, innovate indifferent, vaccine variety little, production technology lag behind, at the basic level vaccine store, it transports cold chains to be system complete. The beast stores and inoculates the result and appraise the system and has not set up yet with vaccine, the bad reaction is monitored and launched with risk assessment less.
|
No comments:
Post a Comment